Repligen | RGEN - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Agilent USD 602M 32M 2025-12
Align Technology USD 121.45M 4.1M 2025-12
Bio Techne USD 91.63M 1.3M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Bruker USD 215.9M 31.5M 2025-12
Charles River Laboratories USD 148.8M 20.82M 2025-12
Danaher USD 1.84B 147M 2025-12
Dentsply International USD 300M 32M 2025-12
Exact Sciences USD 175.87M 46.51M 2025-12
General Electric Aerospace USD 10.08B 593M 2025-12
Henry Schein USD 1.15B 119M 2025-12
Illumina USD 240M 22M 2025-12
IQVIA Holdings USD 3.75B 201M 2025-12
Mettler Toledo International USD 266.63M 19.22M 2025-12
Myriad Genetics USD 31.8M 900K 2025-09
OraSure Technologies USD 6.52M 161K 2025-12
Pacific Biosciences Of California USD 20.77M 4.41M 2025-12
Pfizer USD 5.02B 142M 2025-09
Repligen USD 30.01M 584K 2025-12
Revvity USD 185.46M 9.66M 2025-12
Standard Biotools USD 6.62M 711K 2025-09
Thermo Fisher Scientific USD 3.62B 502M 2025-12
Waters USD 103.78M 11.95M 2025-12
West Pharmaceutical Services USD 253.7M 2.1M 2025-12